BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16856829)

  • 1. Correlation between plasma and urinary caffeine levels in preterm infants.
    Cattarossi L; Violino M; Macagno F; Logreco P; Savoia M
    J Perinat Med; 2006; 34(4):344-6. PubMed ID: 16856829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic aspects of caffeine in premature infants.
    De Carolis MP; Romagnoli C; Muzii U; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A
    Dev Pharmacol Ther; 1991; 16(3):117-22. PubMed ID: 1914785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum caffeine concentrations in preterm neonates.
    Leon AE; Michienzi K; Ma CX; Hutchison AA
    Am J Perinatol; 2007 Jan; 24(1):39-47. PubMed ID: 17195151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental aspects of percutaneous caffeine absorption in premature infants.
    Amato M; Hüppi P; Isenschmid M; Schneider H
    Am J Perinatol; 1992; 9(5-6):431-4. PubMed ID: 1418150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant].
    Morisot C; Simoens C; Trublin F; Lhermitte M; Gremillet C; Robert MH; Lequien P
    Arch Fr Pediatr; 1990 Mar; 47(3):221-4. PubMed ID: 2344252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M; Lipowsky G; Stöckl H; Stiegler H
    Monatsschr Kinderheilkd; 1981 Dec; 129(12):697-702. PubMed ID: 7329425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The choice between theophylline and caffeine in the treatment of apnea in premature infants].
    Bairam A; Boutroy MJ; Badonnel Y; Vert P
    Arch Fr Pediatr; 1990; 47(6):461-5. PubMed ID: 2206108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.
    Lee TC; Charles B; Steer P; Flenady V; Shearman A
    Clin Pharmacol Ther; 1997 Jun; 61(6):628-40. PubMed ID: 9209245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of monitoring theophylline and caffeine plasma levels in the management of neonatal apnea].
    Soto Alvarez J; Sacristán del Castillo JA
    An Esp Pediatr; 1991 Apr; 34(4):310-2. PubMed ID: 2069282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine pharmacokinetics in preterm infants older than 2 weeks.
    Pearlman SA; Duran C; Wood MA; Maisels MJ; Berlin CM
    Dev Pharmacol Ther; 1989; 12(2):65-9. PubMed ID: 2714159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test.
    Pons G; Blais JC; Rey E; Plissonnier M; Richard MO; Carrier O; d'Athis P; Moran C; Badoual J; Olive G
    Pediatr Res; 1988 Jun; 23(6):632-6. PubMed ID: 3134644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
    BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma beta-endorphin concentration and xanthine treatment in apnea of prematurity.
    Sankaran K; Hindmarsh KW; Tan L; Kalapurackal M
    Clin Invest Med; 1993 Jun; 16(3):197-203. PubMed ID: 8365047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].
    Alix D; Berthou F; Riche C; Gouedard H
    Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA
    Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?
    Natarajan G; Botica ML; Thomas R; Aranda JV
    Pediatrics; 2007 May; 119(5):936-40. PubMed ID: 17473094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus intramuscular loading of caffeine in idiopathic apnoea of prematurity.
    Cattarossi L; Colacino V; Janes A; LoGreco P; Rubini S; Zilli M; Macagno F
    Eur J Pediatr; 1988 Dec; 148(3):262-3. PubMed ID: 3063532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.